Nobivac Parvo – C
Nobivac Parvo – C
Authorised
- Canine parvovirus, strain 154, Live
Product identification
Medicine name:
Нобивак Парво – С
Nobivac Parvo – C
Active substance:
- Canine parvovirus, strain 154, Live
Target species:
-
Dog
Route of administration:
-
Subcutaneous use
Product details
Active substance and strength:
-
Canine parvovirus, strain 154, Live7.00/log10 tissue culture infective dose 501.00Dose
Pharmaceutical form:
-
Lyophilisate and solvent for solution for injection
Withdrawal period by route of administration:
-
Subcutaneous use
- Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI07AD01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Bulgaria
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
- INTERVET INTERNATIONAL B.V.
Responsible authority:
- Bulgarian Food Safety Authority
Authorisation number:
- 0022-1889-24.10.2012
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Combined File of all Documents
This document does not exist in this language (English). You can find it in another language below.
Bulgarian (PDF)
Published on: 12/04/2022
How useful was this page?:
